2024. Real-Life Comparative Effectiveness of IL-23 Inhibitors in the Treatment of Moderate to Severe Psoriasis: A Multicenter Experience. Dermatology Practical & Conceptual. 14, 3 (Jul. 2024), e2024179. DOI:https://doi.org/10.5826/dpc.1403a179.